NVO — The Print Record
Novo Nordisk's last 11 earnings prints, scored the way the tape scores them: beat or miss on earnings and revenue, against how the stock actually traded three sessions later (up, flat or down at ±3%). Part of The Print Record — one name per day during earnings season. The name's own page — chart, technicals, quality, peers — is at NVO on Closelooknet.
C — free account
The full NVO card is one free registration away
The reaction chart, the metric that actually carries the print, and the behavior read — plus every archived edition. One email, no password.
Join for freeAlready joined on this browser? The content shows automatically. Looking for the archive, portfolios and real-time signals? That is C+.
Coverage — this week & next
FAQ · from the current data · as of 2026-11-03
Quick answers
How often does Novo Nordisk (NVO) beat earnings estimates?
Across its last 11 covered prints (as of the 2026-11-03 edition), Novo Nordisk beat EPS estimates 9 of 11 times and revenue estimates 9 of 11 times.
How does NVO stock react to earnings?
Measured from the close on print day to the close three sessions later: 4 of the last 11 prints resolved up (beyond +3%), 5 flat, 2 down — with reactions spanning -5.3% to +9.9%. Beat-or-miss and reaction are scored separately because they frequently disagree.
What was NVO's biggest earnings reaction?
+9.9% over the three sessions after the Aug 25 print (2025-08-06), which was a double beat.
When does Novo Nordisk report earnings next?
2026-11-04 (Reported 4 November before the open: EPS $0.89 vs $0.73, revenue ~$11.86B vs ~$11.08B (vendor, per US share) — a beat on both lines; 2026 outlook raised to adjusted sales growth of −2% to +2% at constant exchange rates. Window from Wednesday’s close of 42.18: paid ≥ 43.45, sold < 40.91, scored Monday 9 November: flat, −1.9%. Next print est 3 February 2027 (vendor).). The record and reaction chart on this page update after each print. This is an investment research diary, not advice.
Reactions measured close-of-print-day to the close three sessions later, on adjusted prices. An investment diary, not advice.